Department of Cell Biology and Applied Virology, Fraunhofer Institute for Biomedical Engineering, 66386 St, Ingbert, Germany.
Nanoscale Res Lett. 2011 Aug 23;6(1):505. doi: 10.1186/1556-276X-6-505.
In most conventional in vitro toxicological assays, the response of a complete cell population is averaged, and therefore, single-cell responses are not detectable. Such averaging might result in misinterpretations when only individual cells within a population respond to a certain stimulus. Therefore, there is a need for non-invasive in vitro systems to verify the toxicity of nanoscale materials. In the present study, a micro-sized cell culture chamber with a silicon nitride membrane (0.16 mm2) was produced for cell cultivation and the detection of specific cell responses. The biocompatibility of the microcavity chip (MCC) was verified by studying adipogenic and neuronal differentiation. Thereafter, the suitability of the MCC to study the effects of nanoparticles on a small cell population was determined by using a green fluorescence protein-based reporter cell line. Interleukin-8 promoter (pIL8) induction, a marker of an inflammatory response, was used to monitor immune activation. The validation of the MCC-based method was performed using well-characterized gold and silver nanoparticles. The sensitivity of the new method was verified comparing the quantified pIL8 activation via MCC-based and standard techniques. The results proved the biocompatibility and the sensitivity of the microculture chamber, as well as a high optical quality due to the properties of Si3N4. The MCC-based method is suited for threshold- and time-dependent analysis of nanoparticle-induced IL8 promoter activity. This novel system can give dynamic information at the level of adherent single cells of a small cell population and presents a new non-invasive in vitro test method to assess the toxicity of nanomaterials and other compounds.PACS: 85.35.Be, 81.16.Nd, 87.18.Mp.
在大多数传统的体外毒理学检测中,对完整细胞群体的反应进行平均处理,因此无法检测单细胞反应。当只有群体中的个别细胞对特定刺激产生反应时,这种平均处理可能会导致误解。因此,需要非侵入性的体外系统来验证纳米材料的毒性。在本研究中,制备了一种带有氮化硅膜(0.16mm2)的微尺寸细胞培养室,用于细胞培养和特定细胞反应的检测。通过研究成脂和神经元分化,验证了微腔芯片(MCC)的生物相容性。此后,通过使用基于绿色荧光蛋白的报告细胞系,确定了 MCC 研究小细胞群体中纳米颗粒影响的适用性。白细胞介素 8 启动子(pIL8)诱导,一种炎症反应的标志物,用于监测免疫激活。使用具有良好特征的金和银纳米颗粒验证了基于 MCC 的方法。通过比较基于 MCC 的和标准技术定量的 pIL8 激活,验证了新方法的灵敏度。结果证明了微培养室的生物相容性和灵敏度,以及由于 Si3N4 的特性而具有的高光学质量。基于 MCC 的方法适用于阈值和时间依赖性分析纳米颗粒诱导的 IL8 启动子活性。这种新系统可以提供小细胞群体中贴壁单细胞水平的动态信息,并提出了一种新的非侵入性体外测试方法来评估纳米材料和其他化合物的毒性。
微腔芯片;细胞培养;细胞反应;生物相容性;纳米颗粒;白细胞介素 8 启动子;免疫激活;金纳米颗粒;银纳米颗粒